Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boston Headache Institute is a specialized headache and facial pain care practice in the greater Boston area focused on the diagnosis and treatment of migraine and other headache disorders. It appears to operate as a clinical service line or subsidiary brand associated historically with Boston PainCare and, more recently, with Boston Advanced Medicine/Greater Boston Headache Center in Waltham, Massachusetts. The organization emphasizes multidisciplinary outpatient care, including physician evaluation, procedural and infusion-based treatment approaches, and access to clinical research through affiliated investigators. Publicly available information points to leadership roles held by headache specialists including Zahid H. Bajwa and Egilius L.H. Spierings at different times. It is a healthcare services organization rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boston Headache Institute.